secwatch.observer — SEC 8-K summary
======================================

Issuer:     Palomino Laboratories Inc. (PALX)
CIK:        0001938569
Form:       8-K
Filed at:   2026-05-05T23:59:59+00:00
Accession:  0001493152-26-021282
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Palomino Labs completes $1.88M second closing of private placement; total proceeds $16.98M
--------------------------------------------------------------------------------

- Second closing on Apr 30, 2026: 470,000 shares at $4.00/share, gross proceeds $1,880,000.
- Combined with initial closing (3,773,853 shares at $4.00), total shares 4,243,853 and aggregate proceeds $16,975,412.
- Laidlaw & Company received cash fees (10% of introduced proceeds, 5% of company-introduced) and expense reimbursement.
- Placement agent also received 374,761 warrants at $4.80 exercise price (120% of offering price), 5-year term, cash exercise.
- Offering exempt under Section 4(a)(2) and Rule 506 of the Securities Act to accredited investors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1938569/000149315226021282/0001493152-26-021282-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1938569/000149315226021282/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-021282

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer